From Macleans:
A single course of treatment with the cancer drug rituximab lessens the symptoms of rheumatoid arthritis for up to two years, according to Canadian doctors.
Rituximab (brand name Rituxan) is approved for treatment of a cancer called non-Hodgkin's lymphoma. Because the drug targets a certain type of immune system cell, researchers decided to test it in rheumatoid arthritis, a chronic disease in which the immune system mistakenly attacks the body's own joints, causing pain and swelling. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment